FNDC5 and metabolic disease: 24). Other studies have shown that FNDC5 overexpression improved insulin resistance via AMPK pathway (Ref. 25). At the systemic level, irisin maintains glucose and lipids homoeostasis which is crucial in treatment for type 2 diabetes mellitus (T2DM), obesity or other metabolic diseases (Ref. 26).